References
- Alonso D, Castro A, Martinez A. (2005). Marine compounds for the therapeutic treatment of neurological disorders. Expert Opin Ther Pat 15:1377–86
- Blunt JW, Copp BR, Keyzers RA, et al. (2012). Marine natural products. Nat Prod Rep 29:144–222
- Bores GM, Huger FP, Petko W, et al. (1996). Pharmacological evaluation of novel Alzheimer’s disease therapeutics: Acetylcholinesterase inhibitors related to galanthamine. J Pharmacol Exp Ther 277:728–38
- Bradford MM. (1976). A rapid and sensitive method for the quantitation of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–54
- Cummings JL. (2000). Cholinesterase inhibitors: A new class of psychotropic compounds. Am J Psychiatry 157:4–15
- Cummings JL. (2004). Alzheimer’s disease. N Engl J Med 351:56–67
- Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM. (1961). A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88–95
- Forette F, Anand R, Gharabawi G. (1999). A phase II study in patients with Alzheimer’s disease to assess the preliminary efficacy and maximum tolerated dose of rivastigmine (Exelon). Eur J Neurol 6:423–9
- Ge HM, Peng H, Guo ZK, et al. (2010). Bioactive alkaloids from the plant endophytic fungus Aspergillus terreus. Planta Med 76:822–4
- Glass NL, Donaldson GC. (1995). Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol 61:1323–30
- Hostettmann K, Borloz A, Urbain A, Marston A. (2006). Natural product inhibitors of acetylcholinesterase. Curr Org Chem 10:825–47
- Houghton PJ, Ren Y, Howes MJ. (2006). Acetylcholinesterase inhibitors from plants and fungi. Nat Prod Rep 23:181–99
- Lahiri DK, Rogers JT, Greig NH, Sambamurti K. (2004). Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents. Curr Pharm Des 10:3111–19
- Lee CJ, Subeq YM, Lee RP, et al. (2011). Beneficial effects of enalapril on chlorhexidine digluconate-induced liver peritoneal fibrosis in rats. Chin J Physiol 54:225–34
- Pereira ME, Adams AIH, Silva NS. (2004). 2,5-Hexanedione inhibits rat brain acetylcholinesterase activity in vitro. Toxicol Lett 146:269–74
- Qiao MF, Ji NY, Miao FP, Yin XL. (2011). Steroids and an oxylipin from an algicolous isolate of Aspergillus flavus. Magn Reson Chem 49:366–9
- Rodrigues KF, Costa GL, Carvalho MP, Epifanio RA. (2005). Evaluation of extracts produced by some tropical fungi as potential cholinesterase inhibitors. World J Microbiol Biotechnol 21:1617–21
- Rosales-Corral SA, Acuna-Castroviejo D, Coto-Montes A, et al. (2011). Alzheimer’s disease: Pathological mechanisms and the beneficial role of melatonin. J Pineal Res 52:167–202
- Sangnoi Y, Sakulkeo O, Yuenyongsawad S, et al. (2008). Acetylcholinesterase-inhibiting activity of pyrrole derivatives from a novel marine gliding bacterium, Rapidithrix thailandica. Mar Drugs 6:578–86
- White TJ, Bruns T, Lee S, Taylor J. (1990). Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, eds. PCR Protocols: A Guide to Methods and Applications. New York: Academic Press, 315--22
- Williams P, Sorribas A, Howes MJR. (2011). Natural products as a source of Alzheimer’s drug leads. Nat Prod Rep 28:48–77
- Zheng XY, Zhang ZJ, Chou GX, et al. (2009). Acetylcholinesterase inhibitive activity-guided isolation of two new alkaloids from seeds of Peganum nigellastrum Bunge by an in vitro TLC-bioautographic assay. Arch Pharmacal Res 32:1245–51
- Zhuang P, Tang XX, Yi ZW, et al. (2012). Two new compounds from marine-derived fungus Penicillium sp. F11. J Asian Nat Prod Res 14:197–203